Kintor Pharmaceutical Limited

KNTPF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-$83-$84-$71-$1
Dep. & Amort.$13$9$9$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$3-$14$5-$0
Change in WC$0-$1$0$0
Other Non-Cash$58$78$43$1
Operating Cash Flow-$70-$88-$111-$0
Investing Activities
PP&E Inv.-$1-$1-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$0$1
Inv. Sales/Matur.$0$0$0-$1
Other Inv. Act.$3$4$0-$0
Investing Cash Flow$2$3-$0$0
Financing Activities
Debt Repay.-$6-$14-$2-$10
Stock Issued$1$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$0-$0$10
Financing Cash Flow-$5-$15-$2-$0
Forex Effect$0-$0-$1-$0
Net Chg. in Cash-$13-$24-$18-$0
Supplemental Information
Beg. Cash$20$44$63$1
End Cash$7$20$44$0
Free Cash Flow-$70-$89-$111-$0
Kintor Pharmaceutical Limited (KNTPF) Financial Statements & Key Stats | AlphaPilot